亞士創能(603378.SH)捐贈200萬元支持疫情防控
格隆匯2月2日丨亞士創能(603378.SH)公佈,公司第三屆董事會第二十三次會議於2020年1月27日以通訊表決的方式召開,本次會議以6票同意、0票反對、0票棄權審議通過了《關於捐贈人民幣現金200萬元支持疫情防控的議案》,並授權公司總經理負責捐贈手續及辦理等具體事項。本次捐贈事項在董事會決策權限內,無需提交股東大會審議。
為積極履行社會責任,經公司董事長李金鐘先生提議,公司決定捐贈人民幣現金200萬元支持疫情防控。2020年1月28日,公司200萬元捐贈款項已分別匯入上海市青浦區、安徽省滁州市、安徽省全椒縣三地紅十字會,用於防疫物資採購和疫情防控一線醫務人員慰問嘉獎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.